Barinthus Biotherapeutics PLBRNS
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 15 institutions reported holding Barinthus Biotherapeutics PL (BRNS) in their 13F filings, down 1 from Q4 2024. 3 opened new positions and 4 sold out. The largest holders were M&G PLC ($5.2M), Alphabet Inc. ($1.5M) and HSG Holding Ltd ($1.2M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Barinthus Biotherapeutics PL
- CUSIP
- 91864C107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $62K |
| Exits | 4 | $47K |
All 13F filers, Q4 2024 → Q1 2025: 64,692 shares bought and 296,516 shares sold, net −231,824 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| M&G PLC | 0.03% | No change | 5,197,349 | $5.2M |
| Alphabet Inc. | 0.09% | No change | 1,513,644 | $1.5M |
| HSG Holding Ltd | 0.07% | No change | 1,420,473 | $1.2M |
| DC Funds, LP | 30.22% | No change | 642,204 | $625K |
| Gilead Sciences, Inc. | 0.03% | Reduce -40.4% | 369,855 | $360K |
| Johns Hopkins University | 0.00% | No change | 122,237 | $119K |
| Baird Financial Group, Inc. | 0.00% | No change | 92,461 | $90K |
| HighTower Advisors, LLC | 0.00% | New | 37,450 | $36K |
| Renaissance Technologies | 0.00% | Add +1.7% | 35,700 | $35K |
| Citadel Advisors | 0.00% | New | 26,172 | $26K |
| Janney Montgomery Scott LLC | 0.00% | Add +2.4% | 15,373 | $15K |
| Geode Capital Management, LLC | 0.00% | No change | 11,568 | $11K |
| Morgan Stanley | 0.00% | Reduce -89.1% | 871 | $847 |
| New England Capital Financial Advisors LLC | 0.00% | Reduce -56.7% | 45 | $44 |
| Royal Bank of Canada | 0.00% | New | 105 | $0 |
"% of holder's portfolio" is BRNS's weight in each manager's 13F, not the share of Barinthus Biotherapeutics PL the manager owns.